These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 26621349)

  • 1. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal changes in cognition in young adult cannabis users.
    Becker MP; Collins PF; Schultz A; Urošević S; Schmaling B; Luciana M
    J Clin Exp Neuropsychol; 2018 Aug; 40(6):529-543. PubMed ID: 29058519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
    Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
    Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long lasting effects of chronic heavy cannabis abuse.
    Nestoros JN; Vakonaki E; Tzatzarakis MN; Alegakis A; Skondras MD; Tsatsakis AM
    Am J Addict; 2017 Jun; 26(4):335-342. PubMed ID: 28314070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of HIV and marijuana use on neurocognitive functioning and immune status.
    Thames AD; Mahmood Z; Burggren AC; Karimian A; Kuhn TP
    AIDS Care; 2016; 28(5):628-32. PubMed ID: 26694807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
    Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
    Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E; Martínez-García O; de la Foz VO; Vázquez-Bourgon J; Correa-Ghisays P; Ferro A; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Nov; 201():159-166. PubMed ID: 29861266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
    Rodríguez-Sánchez JM; Ayesa-Arriola R; Mata I; Moreno-Calle T; Perez-Iglesias R; González-Blanch C; Periañez JA; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Dec; 124(1-3):142-51. PubMed ID: 20826079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.
    Jockers-Scherübl MC; Wolf T; Radzei N; Schlattmann P; Rentzsch J; Gómez-Carrillo de Castro A; Kühl KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1054-63. PubMed ID: 17482741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    de Vos C; Leopold K; Blanke ES; Siebert S; Baumgardt J; Burkhardt E; Bechdolf A
    Psychiatry Res; 2020 Nov; 293():113424. PubMed ID: 32862065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
    Rentzsch J; Buntebart E; Stadelmeier A; Gallinat J; Jockers-Scherübl MC
    Schizophr Res; 2011 Aug; 130(1-3):222-7. PubMed ID: 21624823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of synthetic cannabinoids on executive function.
    Cohen K; Kapitány-Fövény M; Mama Y; Arieli M; Rosca P; Demetrovics Z; Weinstein A
    Psychopharmacology (Berl); 2017 Apr; 234(7):1121-1134. PubMed ID: 28160034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.
    Scholes KE; Martin-Iverson MT
    Psychol Med; 2010 Oct; 40(10):1635-46. PubMed ID: 20018124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
    Arnold C; Allott K; Farhall J; Killackey E; Cotton S
    Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.
    Ramaekers JG; Theunissen EL; de Brouwer M; Toennes SW; Moeller MR; Kauert G
    Psychopharmacology (Berl); 2011 Mar; 214(2):391-401. PubMed ID: 21049267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.